535217 — HPC Biosciences Income Statement
0.000.00%
Last trade - 00:00Consumer DefensivesSpeculativeMicro Cap
Annual income statement for HPC Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | IAS | IAS | IAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 16 | 12 | 22.9 | 4.9 | 2.11 |
| Cost of Revenue | |||||
| Gross Profit | 15.6 | 11.2 | 20.3 | -0.583 | 2.11 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 11.1 | 9.43 | 11.8 | 13.9 | 7.35 |
| Operating Profit | 4.88 | 2.57 | 11.1 | -8.98 | -5.24 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 5.77 | 3.59 | 11.9 | -4.81 | 0.286 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 5.54 | 3.37 | 11.7 | -4.94 | 0.212 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 5.54 | 3.37 | 11.7 | -4.94 | 0.212 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 5.54 | 3.37 | 11.7 | -4.94 | 0.211 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.035 | 0.021 | 0.073 | -0.031 | 0.001 |